Role of autophagy genetic variants for the risk of Candida infections

Medical Mycology

Volumn 52, Issue 4, 2014, Pages 333-341

  Rosentul, Diana C ^a   Plantinga, Theo S ^a   Farcas, Marius ^a,b   Oosting, Marije ^a   Hamza, Omar J M ^c   Scott, William K ^d   Alexander, Barbara D ^e   Yang, John C ^f   Laird, Gregory M ^e   Joosten, Leo A B ^a   Van Der Meer, Jos W M ^a   Perfect, John R ^e   Kullberg, Bart Jan ^a   Van Der Ven, Andre J A M ^a   Johnson, Melissa D ^e,g   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f DEPARTMENT OF MEDICINE   (United States)

^g Campbell University   (United States)

Author keywords

Autophagy; Candida albicans; Candidemia; Genetic association study; HIV; Oropharyngeal candidiasis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; ATG16L1 PROTEIN, HUMAN; CARRIER PROTEIN; CYTOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; IRGM PROTEIN, HUMAN;

ARTICLE; ATG16L1 GENE; AUTOPHAGY; CANDIDEMIA; CANDIDIASIS; CYTOKINE PRODUCTION; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; IRGM GENE; OROPHARYNX CANDIDIASIS; SINGLE NUCLEOTIDE POLYMORPHISM; TANZANIA; AFRICA; COHORT ANALYSIS; EUROPE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; RISK ASSESSMENT; SECRETION (PROCESS); AFRICAN; CONTROLLED STUDY; EUROPEAN; FUNGAL GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN CELL; MAJOR CLINICAL STUDY;

AFRICA; AUTOPHAGY; CANDIDIASIS; CARRIER PROTEINS; COHORT STUDIES; CYTOKINES; EUROPE; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEINS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT;

CANDIDA; CANDIDA ALBICANS;

EID: 84902971085     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myt035     Document Type: Article

References (37)

1. Webb BC, Thomas CJ, Willcox MDP, Harty DWS, Knox KW. Candida-associated denture stomatitis. Aetiology and management: A review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust Dent J 1998; 43: 45-50.
2. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007; 45: 321-346.
3. Spellberg B. Novel insights into disseminated candidiasis: Pathogenesis research and clinical experience converge. Plos Pathog 2008;4.
4. Barreiro LB, Ben-Ali M, Quach H et al. Evolutionary dynamics of human toll-like receptors and their different contributions to host defense. Plos genet 2009;5.
5. Goodman DS, Teplitz ED, Wishner A et al. Prevalence of cutaneous disease in patients with acquired-immunodeficiencysyndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 1987; 17: 210-220.
6. Phelan JA, Saltzman BR, Friedland GH, Klein RS. Oral findings in patients with acquired-immunodeficiency-syndrome. Oral Surg Oral Med O 1987; 64: 50-56.
7. Feigal DW, Katz MH, Greenspan D et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San-Francisco epidemiological cohorts. Aids 1991; 5: 519-525.
8. Degregorio MW, Lee WMF, Ries CA. Candida infections in patients with acute-leukemia-ineffectiveness of nystatin prophylaxis and relationship between orophayngeal and systemic candidiasis. Cancer 1982; 50: 2780-2784.
9. Plantinga TS, Johnson MD, Scott WK et al. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 2012; 205: 934-943.
10. Plantinga TS, van der Velden W, Ferwerda B et al. Early stop polymorphism in human DECTIN-1 is associated with increased Candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 2009; 49: 724-732.
11. Ferwerda B, Ferwerda G, Plantinga TS et al. Human dectin- 1deficiency and mucocutaneous fungal infections. N Engl Journal Med 2009; 361: 1760-1767.
12. Glocker EO, Hennigs A, NabaviMet al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl Journal Med 2009; 361: 1727-1735.
13. Stromhaug PE, Klionsky DJ. Approaching the molecular mechanism of autophagy. Traffic 2001; 2: 524-531.
14. Nicola AM, Albuquerque P, Martinez LR et al.Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infect Immun 2012; 80: 3065-3076.
15. Kuballa P, Huett A, Rioux JD, Daly MJ, Xavier RJ. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. Plos One 2008;3.
16. Hampe J, Franke A, Rosenstiel P, Till A et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211.
17. Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596-604.
18. Franke A, Balschun T, Karlsen TH et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008; 40: 713-715.
19. Cooney R, Baker J, Brain O et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16: 90-97.
20. Plantinga TS, Crisan TO, Oosting M et al. Crohn's disease-associated ATG16L1 polymorphism modulates proinflammatory cytokine responses selectively upon activation of NOD2. Gut 2011; 60: 1229-1235.
21. Glubb DM, Gearry RB, BarclayML et al. NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease. World J Gastroentero 2011;17.
22. Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007; 39: 830-832.
23. McCarroll SA, Huett A, Kuballa P et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008; 40: 1107-1112.
24. Smeekens SP, Malireddi RK, Plantinga TS et al. Autophagy is redundant for the host defense against systemic Candida albicans infections. Eur J Clin Microbiol Infect Dis 2013 (In Press); DOI:10.1007/s10096-013-2002-x.
25. Standaert-Vitse A, Jouault T, Vandewalle P et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 2006; 130: 1764-1775.
26. Quinton J-F, Sendid B, Reumaux D et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-791.
27. Castro KG, Ward JW, Slutsker L et al. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clin Infect Dis 1993; 17: 802-810.
28. Kramer IRH, Pindborg JJ, Bezroukov V, Sardo Infirri J. Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. Community Dent Oral Epidemiol 1980; 8: 1-26.
29. Plantinga TS, Hamza OJM,Willment JA et al. Genetic variation of innate immune genes in HIV-infected African patients with or without oropharyngeal candidiasis. J Acquir Immune Defic Syndr 2010; 55: 87-94.
30. Rosentul DC, Plantinga TS, Oosting M et al. Genetic variation in the dectin-1/cARD9 recognition pathway and susceptibility to candidemia. J Infect Dis 2011; 204: 1138-1145.
31. Venselaar H, Te Beek TA, Kulpers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics 2010; 11: 548-558.
32. Che NY, Li S, Gao TJ et al. Identification of a novel IRGM promoter single nucleotide polymorphism associated with tuberculosis. Clin Chim Acta 2010; 411: 1645-1649.
33. Collazo CM, Yap GS, Sempowski GD et al. Inactivation of LRG- 47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J ExpMed 2001; 194: 181-187.
34. Taylor GA, Feng CG, Sher A. P47 GTPases: Regulators of immunity to intracellular pathogens. Nature Rev Immunol 2004; 4: 100-109.
35. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003; 302: 654-659.
36. Crisan TO, Plantinga TS, de Veerdonk FLv et al. Inflammasomeindependent modulation of cytokine response by autophagy in human cells. Plos One 2011;6.
37. Nakagawa I, Amano A, Mizushima N et al. Autophagy defends cells against invading group a Streptococcus. Science 2004; 306: 1037-1040.